Mark Hew
Mark Hew
Head of Allergy, Asthma & Clinical Immunology, Alfred Health
Verified email at alfred.org.au
Title
Cited by
Cited by
Year
Characterization of the severe asthma phenotype by the national heart, lung, and blood institute's severe asthma research program
WC Moore, ER Bleecker, D Curran-Everett, SC Erzurum, BT Ameredes, ...
Journal of Allergy and Clinical Immunology 119 (2), 405-413, 2007
8762007
Increased expression of transient receptor potential vanilloid-1 in airway nerves of chronic cough
DA Groneberg, A Niimi, QT Dinh, B Cosio, M Hew, A Fischer, KF Chung
American journal of respiratory and critical care medicine 170 (12), 1276-1280, 2004
4332004
Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma
M Hew, P Bhavsar, A Torrego, S Meah, N Khorasani, PJ Barnes, I Adcock, ...
American journal of respiratory and critical care medicine 174 (2), 134-141, 2006
3012006
Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma
P Bhavsar, M Hew, N Khorasani, A Torrego, PJ Barnes, I Adcock, ...
Thorax 63 (9), 784-790, 2008
2752008
National Heart, Lung, and Blood Institute's Severe Asthma Research Program. Identification of asthma phenotypes using cluster analysis in the severe asthma research program
WC Moore
Am J Respir Crit Care Med 181, 315-323, 2010
1932010
Correlation of systemic superoxide dismutase deficiency to airflow obstruction in asthma
SAA Comhair, KS Ricci, M Arroliga, AR Lara, RA Dweik, W Song, ...
American journal of respiratory and critical care medicine 172 (3), 306-313, 2005
1872005
Effect of p38 MAPK inhibition on corticosteroid suppression of cytokine release in severe asthma
P Bhavsar, N Khorasani, M Hew, M Johnson, KF Chung
European Respiratory Journal 35 (4), 750-756, 2010
1182010
Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial
WW Busse, ER Bleecker, JM FitzGerald, GT Ferguson, P Barker, ...
The Lancet Respiratory Medicine 7 (1), 46-59, 2019
1142019
Expression and activation of TGF-β isoforms in acute allergen-induced remodelling in asthma
A Torrego, M Hew, T Oates, M Sukkar, KF Chung
Thorax 62 (4), 307-313, 2007
1132007
Comorbidities in difficult asthma are independent risk factors for frequent exacerbations, poor control and diminished quality of life
TR Tay, N Radhakrishna, F Hore‐Lacy, C Smith, R Hoy, E Dabscheck, ...
Respirology 21 (8), 1384-1390, 2016
1102016
Bronchoscopic evaluation of the mediastinum using endobronchial ultrasound: a description of the first 216 cases carried out at an Australian tertiary hospital
DP Steinfort, MJ Hew, LB Irving
Internal medicine journal 41 (12), 815-824, 2011
1062011
Inflammatory biomarkers in airways of patients with severe asthma compared with non‐severe asthma
P Macedo, M Hew, A Torrego, S Jouneau, T Oates, A Durham, KF Chung
Clinical & Experimental Allergy 39 (11), 1668-1676, 2009
952009
The Melbourne epidemic thunderstorm asthma event 2016: an investigation of environmental triggers, effect on health services, and patient risk factors
F Thien, PJ Beggs, D Csutoros, J Darvall, M Hew, JM Davies, PG Bardin, ...
The Lancet Planetary Health 2 (6), e255-e263, 2018
912018
Oral retinoids and pregnancy
A Chan, M Hanna, M Abbott, RJ Keane
Medical journal of Australia 165 (3), 164-167, 1996
90*1996
Comorbid “treatable traits” in difficult asthma: current evidence and clinical evaluation
TR Tay, M Hew
Allergy 73 (7), 1369-1382, 2018
872018
Evidence-based practice
S Hamer
Achieving evidence-based practice: a handbook for practitioners, 3-12, 1999
831999
Corticosteroid suppression of lipoxin A 4 and leukotriene B 4 from alveolar macrophages in severe asthma
PK Bhavsar, BD Levy, MJ Hew, MA Pfeffer, S Kazani, E Israel, KF Chung
Respiratory research 11 (1), 1-9, 2010
692010
Safety of investigative bronchoscopy in the Severe Asthma Research Program
WC Moore, MD Evans, ER Bleecker, WW Busse, WJ Calhoun, M Castro, ...
Journal of Allergy and Clinical Immunology 128 (2), 328-336. e3, 2011
632011
Treatable traits can be identified in a severe asthma registry and predict future exacerbations
VM McDonald, SA Hiles, K Godbout, ES Harvey, GB Marks, M Hew, ...
Respirology 24 (1), 37-47, 2019
612019
Nonadherence in the era of severe asthma biologics and thermoplasty
J Lee, TR Tay, N Radhakrishna, F Hore-Lacy, A Mackay, R Hoy, ...
European Respiratory Journal 51 (4), 2018
602018
The system can't perform the operation now. Try again later.
Articles 1–20